Data updated: Mar 10, 2026
CAFCIT
CAFFEINE CITRATE
Approved 1999-09-21
2
Indications
--
Phase 3 Trials
1
Priority Reviews
26
Years on Market
Details
- Status
- Prescription
- First Approved
- 1999-09-21
- Routes
- INTRAVENOUS, ORAL
- Dosage Forms
- SOLUTION
CAFCIT Approval History
Loading approval history...
What CAFCIT Treats
1 indicationsCAFCIT is approved for 1 conditions since its original approval in 1999. These indications span multiple therapeutic areas including oncology, immunology, and more.
- Apnea of Prematurity
Source: FDA Label
🔬
Pro Active Pipeline
Ongoing clinical trials by development phase
Loading...
⭐
Pro Key Completed Trials
Completed studies with published results, ranked by significance
Loading...
📊
Trial Timeline
Full development history with FDA approval milestones
Loading...
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
CAFCIT FDA Label Details
ProIndications & Usage
FDA Label (PDF)CAFCIT (caffeine citrate) is indicated for the treatment of apnea of prematurity.
Want competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.